TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndrome

TLR9通过降低FOXO3表达来防止巨噬细胞活化综合征中的过度炎症反应。

阅读:4
作者:Mengyan Wang,Yuning Ma,Jianfen Meng,Chengde Yang,Dehao Zhu,Xia Chen,Longfang Chen,Yu Xiao,Da Yi,Hui Shi,Yue Sun,Honglei Liu,Xiaobing Cheng,Yutong Su,Junna Ye,Huihui Chi,Zhuochao Zhou,Tingting Liu,Fan Wang,Jialin Teng,Ping Hu,Jinchao Jia,Qiongyi Hu

Abstract

Adult-onset Still's disease (AOSD) is characterized by an overwhelming inflammatory response and hyperactivation of monocytes/macrophages, which may cause macrophage activation syndrome (MAS). Here, we demonstrate the forkhead box protein O3 (FOXO3), a transcriptional factor downregulated by interferon, as an important regulator of inflammation in AOSD-MAS. FOXO3 expression is downregulated in monocytes/PBMCs from patients with AOSD, especially in those developing MAS. A negative correlation between FOXO3 expression with disease activity and inflammatory level is identified. FOXO3 downregulation can be induced by TLR9 activation both in the murine MAS model and TLR9 agonist-stimulated macrophages in vitro, through transcriptional regulation and phosphorylation by AKT. Depletion of Foxo3 protected mice from hyperinflammatory response and organ damage in MAS, and mechanistically, alleviated NLRP3 inflammasome activation in macrophages. Our study reveals mechanisms of FOXO3 in facilitating AOSD-MAS development and identifies the critical role of FOXO3 in the self-negative regulation of inflammation in AOSD through suppression by TLR9 signaling.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。